In contrast, ZNRF3 mutations were observed in only 3% of HCC (Schulze et al., 2015) and RSPO fusions are rare, although elevated RSPO2 was seen in a subset of HCC patients. This evidence concerns the gene RSPO1 and hepatocellular carcinoma.